Relationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAIDs hypersensitivity

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Pacor, Maria Luisa ^a   Di Lorenzo, Gabriele ^b   Mansueto, Pasquale ^b   Martinelli, Nicola ^a   Esposito Pellitteri, Maria ^b   Pradella, Paola ^c   Uxa, Laura ^c   Di Fede, Gaetana ^b   Rini, GiovamBattista ^b   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HLA A11 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA B13 ANTIGEN; HLA B44 ANTIGEN; HLA C ANTIGEN; HLA CW4 ANTIGEN; HLA CW5 ANTIGEN; HLA CW7 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CHRONIC DISEASE; CHRONIC IDIOPATHIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; URTICARIA; ALLELE; CASE CONTROL STUDY; GENE; GENE FREQUENCY; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHENOTYPE; RISK FACTOR;

ADULT; ALLELES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; URTICARIA;

EID: 34247178607     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/62489     Document Type: Article

References (20)

1. M W Greaves Urticaria. Clinical Allergy and Immunology 16 2002 381 400
2. C E Grattan clive.grattan@nnuh.nhs.uk The urticaria spectrum: recognition of clinical patterns can help management. Clinical and Experimental Dermatology 29 3 2004 217 221
3. C E Grattan R A Sabroe M W Greaves Chronic urticaria. Journal of the American Academy of Dermatology 46 5 2002 645 657
4. A P Kaplan kaplana@musc.edu Chronic urticaria: pathogenesis and treatment. Journal of Allergy and Clinical Immunology 114 3 2004 465 474
5. G Di Lorenzo M L Pacor P Mansueto Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. International Archives of Allergy and Immunology 138 3 2005 235 242
6. J G Bodmer S G Marsh E D Albert Nomenclature for factors of the HLA system, 1996. Human Immunology 53 1 1997 98 128
7. H G Rammensee T Friede S Stevanovic MHC ligands and peptide motifs: first listing. Immunogenetics 41 4 1995 178 228
8. R Heard R Lechler HLA and autoimmune disease. HLA and Disease Academic Press London, UK 1994 123 151
9. G Nuki Ankylosing spondylitis, HLA B27, and beyond. Lancet 351 9105 1998 767 769
10. G Di Lorenzo M L Pacor P Mansueto Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. Journal of Allergy and Clinical Immunology 114 3 2004 619 625
11. G Di Lorenzo M L Pacor A M Vignola Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients. Allergy 57 12 2002 1180 1186
12. M L Pacor G Di Lorenzo D Biasi M Barbagallo R Corrocher Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clinical and Experimental Allergy 32 3 2002 397 400
13. M L Pacor G Di Lorenzo R Corrocher Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clinical and Experimental Allergy 31 10 2001 1607 1614
14. S H Kim J H Choi K W Lee The human leucocyte antigen- DRB1 *1302 -DQB1 *0609 -DPB1 *0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clinical and Experimental Allergy 35 3 2005 339 344
15. B F O'Donnell C M O'Neill D M Francis Human leucocyte antigen class II associations in chronic idiopathic urticaria. British Journal of Dermatology 140 5 1999 853 858
16. P Oztas M Onder S Gonen M O Oztas O Soylemezoglu Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Medical Journal 45 2004 3 392 395
17. J C Roujeau T N Huynh C Bracq J C Guillaume J Revuz R Touraine Genetic susceptibility to toxic epidermal necrolysis. Archives of Dermatology 123 9 1987 1171 1173
18. J C Roujeau C Bracq N T Huyn E Chaussalet C Raffin N Duedari HLA phenotypes and bullous cutaneous reactions to drugs. Tissue Antigens 28 4 1986 251 254
19. S-I Hung W-H Chung L-B Liou HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proceedings of the National Academy of Sciences of the United States of America 102 11 2005 4134 4139
20. C S Falk D J Schendel schendel@ifi.med.uni-muenchen.de HLA-C revisited. Ten years of change. Immunologic Research 16 2 1997 203 214